These data are in accordance with the previous studies by Romero [8], Silverstein [7], and Sopik [9], where patients with ILR after prior ipsilateral DCIS mainly had same good prognosis features (stage I tumors, SBR grade II, and positive ER status). The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.